Search Results
Investor Update: ANGLE reports positive data from Parsortix FDA clinical study
Shares Investor Evening Angle
Shares Investor Evening Angle
ANGLE PLC: Proactive One2One Virtual Conference
Andrew Newland, Chief Executive and Ian Griffiths, Finance Director of ANGLE (AGL)
Investor Evening Angle: 15 April 2015
ANGLE boss on breakthrough ovarian cancer results
Angle (AGL) – Andrew Newland, Chief Executive
ANGLE present at the Proactive One2One live virtual conference
ANGLE (AGL) - Andrew Newland, Chief Executive & Ian Griffiths, FD
Andrew Newland, Chief Executive of ANGLE (AGL)
ANGLE plc Presentation to Biotech Showcase Jan21
